CD37 and neoplasm: Furthermore, a combination of antibodies targeting CD37 (IgG1-CD37.3-RGE) and CD20 (IgG1-11B8-AGK) induced potent and mutually dependent CDC on a CD37+CD20+ tumor cell line (Fig. 6d).